These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3099 related articles for article (PubMed ID: 6382953)

  • 1. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
    Chou TC; Talalay P
    Adv Enzyme Regul; 1984; 22():27-55. PubMed ID: 6382953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the combined effect of two linear inhibitors on a single enzyme.
    Martinez-Irujo JJ; Villahermosa ML; Mercapide J; Cabodevilla JF; Santiago E
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):689-98. PubMed ID: 9445400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new plot for multiple enzyme inhibition.
    Palatini P
    Biochem Int; 1983 Aug; 7(2):247-53. PubMed ID: 6383391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
    Palatini P
    Mol Pharmacol; 1983 Jul; 24(1):30-41. PubMed ID: 6865924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.
    Chou TC; Talalay P
    J Biol Chem; 1977 Sep; 252(18):6438-42. PubMed ID: 893418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.
    Chou TC
    Pharmacol Rev; 2006 Sep; 58(3):621-81. PubMed ID: 16968952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Kinetic Process to Determine the Interaction Type Between Two Compounds, One of Which Is a Reaction Product, Using Alkaline Phosphatase Inhibition as a Case Study.
    Bezerra RMF; Pinto PA; Dias AA
    Appl Biochem Biotechnol; 2020 Jun; 191(2):657-665. PubMed ID: 31845192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical simulation of the interaction of drugs that inhibit deoxyribonucleic acid biosynthesis.
    Werkheiser WC; Grindey GB; Moran RG
    Mol Pharmacol; 1973 May; 9(3):320-9. PubMed ID: 4736290
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple kinetic method for rapid mechanistic analysis of reversible enzyme inhibitors.
    Lai CJ; Wu JC
    Assay Drug Dev Technol; 2003 Aug; 1(4):527-35. PubMed ID: 15090249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the median method to estimate the kinetic constants of the substrate uncompetitive inhibition equation.
    Valencia PL; Astudillo-Castro C; Gajardo D; Flores S
    J Theor Biol; 2017 Apr; 418():122-128. PubMed ID: 28130095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical modeling of the effects of drug combinations.
    Plummer JL; Short TG
    J Pharmacol Methods; 1990 Jul; 23(4):297-309. PubMed ID: 2196402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A checkerboard method to evaluate interactions between drugs.
    Martinez-Irujo JJ; Villahermosa ML; Alberdi E; Santiago E
    Biochem Pharmacol; 1996 Mar; 51(5):635-44. PubMed ID: 8615900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical versus clinical drug combination studies.
    Chou TC
    Leuk Lymphoma; 2008 Nov; 49(11):2059-80. PubMed ID: 19021049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of drug interactions in combined drug therapy by reflection method.
    Zheng QS; Sun RY
    Acta Pharmacol Sin; 2000 Feb; 21(2):183-7. PubMed ID: 11263269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol.
    Slama JT; Aboul-Ela N; Jacobson MK
    J Med Chem; 1995 Oct; 38(21):4332-6. PubMed ID: 7473561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational approach to the clinical protocol design for drug combinations: a review.
    Chang TT; Chou TC
    Acta Paediatr Taiwan; 2000; 41(6):294-302. PubMed ID: 11198934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deviations from Michaelis-Menten kinetics. The possibility of complicated curves for simple kinetic schemes and the computer fitting of experimental data for acetylcholinesterase, acid phosphatase, adenosine deaminase, arylsulphatase, benzylamine oxidase, chymotrypsin, fumarase, galactose dehydrogenase, beta-galactosidase, lactate dehydrogenase, peroxidase and xanthine oxidase.
    Bardsley WG; Leff P; Kavanagh J; Waight RD
    Biochem J; 1980 Jun; 187(3):739-65. PubMed ID: 6821369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.
    Chou TC; Talalay P
    Eur J Biochem; 1981 Mar; 115(1):207-16. PubMed ID: 7227366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 155.